MA27763A1 - Composes n-formyl-hydroxylamine cristallins - Google Patents

Composes n-formyl-hydroxylamine cristallins

Info

Publication number
MA27763A1
MA27763A1 MA28547A MA28547A MA27763A1 MA 27763 A1 MA27763 A1 MA 27763A1 MA 28547 A MA28547 A MA 28547A MA 28547 A MA28547 A MA 28547A MA 27763 A1 MA27763 A1 MA 27763A1
Authority
MA
Morocco
Prior art keywords
formyl
crystalline
hydroxylamine compounds
compounds
7alkanes
Prior art date
Application number
MA28547A
Other languages
English (en)
Inventor
Martin Muller
Hui Liu
Joginder Singh Bajwa
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33131903&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA27763(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MA27763A1 publication Critical patent/MA27763A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Certains composés de N-formyl-hydroxylamine, tels que des N-[1-oxo-2-alkyl-3-(N-hydroxyformamido)-propyl]-(carbonylamino-aryl- ou -hétéroaryl)-azacyclo4-7alcanes ou thiazacyclo4-7alcanes ou imidazacyclo4-7-alcanes, sont utiles dans le traitement d'infections bactériennes. Il est décrit des sels cristallins de tels composés de formule (I), dans laquelle M est un métal mono- ou divalent ; a vaut 1/2 ou 1.
MA28547A 2003-04-02 2005-10-11 Composes n-formyl-hydroxylamine cristallins MA27763A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45972603P 2003-04-02 2003-04-02

Publications (1)

Publication Number Publication Date
MA27763A1 true MA27763A1 (fr) 2006-02-01

Family

ID=33131903

Family Applications (1)

Application Number Title Priority Date Filing Date
MA28547A MA27763A1 (fr) 2003-04-02 2005-10-11 Composes n-formyl-hydroxylamine cristallins

Country Status (25)

Country Link
US (1) US20070135353A1 (fr)
EP (1) EP1613305A1 (fr)
JP (1) JP2006522054A (fr)
KR (1) KR20060002915A (fr)
CN (1) CN1764450A (fr)
AR (1) AR043804A1 (fr)
AU (1) AU2004226815B2 (fr)
BR (1) BRPI0409009A (fr)
CA (1) CA2520682A1 (fr)
CL (1) CL2004000705A1 (fr)
CO (1) CO5630028A2 (fr)
EC (1) ECSP056043A (fr)
IS (1) IS8093A (fr)
MA (1) MA27763A1 (fr)
MX (1) MXPA05010610A (fr)
MY (1) MY136854A (fr)
NO (1) NO20055097L (fr)
NZ (1) NZ542432A (fr)
PE (1) PE20050392A1 (fr)
RU (1) RU2005133660A (fr)
SG (1) SG166681A1 (fr)
TN (1) TNSN05248A1 (fr)
TW (1) TW200427458A (fr)
WO (1) WO2004087133A1 (fr)
ZA (1) ZA200507179B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1406893B1 (fr) 2001-06-15 2007-04-18 Vicuron Pharmaceuticals, Inc. COMPOSeS BICYCLIQUES DE PYRROLIDINE
WO2004026824A1 (fr) 2002-09-19 2004-04-01 Novartis Ag Procede de preparation d'intermediaires
EP1599440A2 (fr) 2003-02-21 2005-11-30 Novartis AG Procede chimique pour la preparation d'intermediaires pour obtenir des composes n-formyl hydroxylamines
GT200600196A (es) * 2005-05-23 2007-01-15 Compuestos n-formil de hidroxilamina
EP3483155B1 (fr) * 2016-05-11 2022-10-26 Guangdong Hebo Pharmaceutical Co., Ltd. Inhibiteur de peptide déformylase à noyau spiro à trois ou cinq chaînons et son utilisation comme agent anti-cancereux

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3282986A (en) * 1960-10-06 1966-11-01 Merck & Co Inc N-acylated hydroxamic acids and derivatives thereof
HUP0102901A3 (en) * 1998-02-07 2002-12-28 British Biotech Pharm Use of n-formyl hydroxylamines as antibacterial agents
AR036053A1 (es) * 2001-06-15 2004-08-04 Versicor Inc Compuestos de n-formil-hidroxilamina, un proceso para su preparacion y composiciones farmaceuticas

Also Published As

Publication number Publication date
CN1764450A (zh) 2006-04-26
ZA200507179B (en) 2006-04-26
ECSP056043A (es) 2006-01-27
AU2004226815B2 (en) 2007-07-19
US20070135353A1 (en) 2007-06-14
EP1613305A1 (fr) 2006-01-11
CL2004000705A1 (es) 2005-01-14
SG166681A1 (en) 2010-12-29
NZ542432A (en) 2009-04-30
TNSN05248A1 (en) 2007-06-11
BRPI0409009A (pt) 2006-03-28
NO20055097D0 (no) 2005-11-01
JP2006522054A (ja) 2006-09-28
IS8093A (is) 2005-10-27
RU2005133660A (ru) 2006-06-10
CO5630028A2 (es) 2006-04-28
TW200427458A (en) 2004-12-16
PE20050392A1 (es) 2005-06-19
AR043804A1 (es) 2005-08-10
MY136854A (en) 2008-11-28
NO20055097L (no) 2005-12-22
WO2004087133A1 (fr) 2004-10-14
AU2004226815A1 (en) 2004-10-14
MXPA05010610A (es) 2005-11-23
KR20060002915A (ko) 2006-01-09
CA2520682A1 (fr) 2004-10-14

Similar Documents

Publication Publication Date Title
MA27946A1 (fr) Omega-carboxyaryldiphenyluree fluoro-substituee pour le traitement et la prevention de maladies et d'etats pathologiques.
MA27643A1 (fr) Utilisation de n-alkyl-4-methyleneamino-3-hydroxy-2-pyridones en tant qu'agents antimicrobiens
IL171977A0 (en) Cyclic sulfonamides for inhibition of gamma-secretase
DE602004007808D1 (de) Neue gamma secretase inhibitoren
NO20024424D0 (no) Glykopyranosyloksybenzylbenzenderivater, medisinske sammensetninger inneholdende slike, samt intermediater tilfremstilling av derivatene
NO20053246L (no) Kondensert 1,3-dihydroimidazol-ringforbindelse.
ATE444293T1 (de) Cyclische sulfamide zur inhibierung von gamma- sekretase
TNSN04164A1 (fr) Inhibiteurs de acc.
ATE464287T1 (de) Cyclohexyl-sulphone als gamma-sekretase- inhibitoren
ATE435219T1 (de) Heteroaryl substituierte spirocyclische sulfamide zur hemmung von gamma sekretase
MA27774A1 (fr) Inhibiteurs de phosphatidylinositol 3-kinase
MA31894B1 (fr) Composes organiques
TNSN02022A1 (fr) Triazolopyridines anti-inflammatoires nouvelles, et compositions les contenant
ATE389395T1 (de) Substituierte 2-aminotetraline zur vorbeugenden behandlung von morbus parkinson
MA27763A1 (fr) Composes n-formyl-hydroxylamine cristallins
ATE270667T1 (de) 2-amino-benzoxazinone zur behandlung von viralen infektionen
SE0101082D0 (sv) Novel use
MA27549A1 (fr) N-sulfonyl-4-methylene-amino-3-hydroxy-2-pyridones
EP1325918A4 (fr) Inhibiteurs de l'apoptose des cellules du muscle cardiaque et agents therapeutiques/prophylactiques contre les maladies cardiaques
MXPA02011553A (es) N-hidroxiformamidas sustituidas por biciclico heterobiciclilmetansulfonilamino.
DK1541553T3 (da) Indolinforbindelse samt medicinsk anvendelse deraf
TH70058A (th) อนุพันธ์ 2, 3 -ไดแอริล-ไพราโซลิดีนชนิดใหม่ที่เป็นตัวยับยั้งเอนไซม์ที่ทำให้นิวโรเทนซินเสื่อมสลาย
ZA882775B (en) Pharmaceutical use of organic compounds
MA29934B1 (fr) Traitement des symptomes de l'irritation vesicale
TH60570A3 (th) ตัวกระทำไอโซซาโซลิโนนชนิดใหม่ที่มีฤทธิ์ในการต่อต้านแบคทีเรีย